MedTrace Logo

Culturally Adapted Psychological Intervention for Bipolar Disorder in Pakistan

NCT02210390 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2016-12-23

No results posted yet for this study

Summary

Aim:

To assess the Feasibility RCT of the efficacy of a culturally adapted psychological intervention for Bipolar disorder in Pakistan

Design:

Randomized Control Trial

Setting:

Psychiatric Departments of different Hospitals in Karachi.

Participants:

A total of 36 Bipolar disorder patients will be randomized to psychological Intervention and treatment as usual arm.

Intervention:

Culturally Adapted psychological intervention for bipolar disorder

Outcome measure:

* Acceptance of intervention in terms of attending session and dropouts
* Knowledge and attitudes towards bipolar disorder

Conditions

Interventions

BEHAVIORAL

Psycho education

Psycho-education Sessions will be offered weekly basis

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER

  • Dow University of Health Sciences

    collaborator OTHER

  • Abbasi Shaheed Hospital

    collaborator OTHER

  • Pakistan Institute of Living and Learning

    lead OTHER

Principal Investigators

  • Nusrat Husain, MD · Pakistan Institute of Learning and Living, University of Manchester

  • Imran Chaudhry, MD · University of Manchester

  • Farooq Naeem, MRCPsych · Pakistan Institute of Learning and Living, University of Southampton

  • Raza Ur Rehman, FCPS · Dow University of Health Sciences

  • Ajmal kazm · Pakistan Institute of Living and Learning

  • Munir Hamirani, FCPS · Abbasi Shaheed Hospital

  • Muhammad I Husain, MRCPsych · Camden and Islington NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02210390 on ClinicalTrials.gov